Jeffrey E. Russel

Array ( [id] => 3762924 [patent_doc_number] => 05741895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Identification of cell density signal molecule' [patent_app_type] => 1 [patent_app_number] => 8/445367 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9003 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741895.pdf [firstpage_image] =>[orig_patent_app_number] => 445367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3982891 [patent_doc_number] => 05958877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide' [patent_app_type] => 1 [patent_app_number] => 8/446929 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 4181 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958877.pdf [firstpage_image] =>[orig_patent_app_number] => 446929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993805 [patent_doc_number] => 05919761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Peptides for heparin and low molecular weight heparin anticoagulation reversal' [patent_app_type] => 1 [patent_app_number] => 8/436703 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 10845 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919761.pdf [firstpage_image] =>[orig_patent_app_number] => 436703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850588 [patent_doc_number] => 05767083 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent' [patent_app_type] => 1 [patent_app_number] => 8/432651 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27714 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767083.pdf [firstpage_image] =>[orig_patent_app_number] => 432651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808499 [patent_doc_number] => 05788959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Drug delivery device and method for employing the same' [patent_app_type] => 1 [patent_app_number] => 8/426980 [patent_app_country] => US [patent_app_date] => 1995-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6684 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/788/05788959.pdf [firstpage_image] =>[orig_patent_app_number] => 426980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730465 [patent_doc_number] => 05665594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Gas permeable bioreactor and method of use' [patent_app_type] => 1 [patent_app_number] => 8/416908 [patent_app_country] => US [patent_app_date] => 1995-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 6020 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665594.pdf [firstpage_image] =>[orig_patent_app_number] => 416908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945464 [patent_doc_number] => 05977061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'N.sup.6 - substituted nucleotide analagues and their use' [patent_app_type] => 1 [patent_app_number] => 8/426372 [patent_app_country] => US [patent_app_date] => 1995-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13457 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977061.pdf [firstpage_image] =>[orig_patent_app_number] => 426372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700849 [patent_doc_number] => 05646109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Convertible microemulsion formulations' [patent_app_type] => 1 [patent_app_number] => 8/425475 [patent_app_country] => US [patent_app_date] => 1995-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16753 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646109.pdf [firstpage_image] =>[orig_patent_app_number] => 425475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682352 [patent_doc_number] => 05633226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Convertible microemulsion formulations' [patent_app_type] => 1 [patent_app_number] => 8/425787 [patent_app_country] => US [patent_app_date] => 1995-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16754 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633226.pdf [firstpage_image] =>[orig_patent_app_number] => 425787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697809 [patent_doc_number] => 05596078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Synthesis of cyclic peptides' [patent_app_type] => 1 [patent_app_number] => 8/423415 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3613 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/596/05596078.pdf [firstpage_image] =>[orig_patent_app_number] => 423415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661463 [patent_doc_number] => 05656604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Peptide compound and its preparation' [patent_app_type] => 1 [patent_app_number] => 8/422944 [patent_app_country] => US [patent_app_date] => 1995-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37661 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656604.pdf [firstpage_image] =>[orig_patent_app_number] => 422944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093952 [patent_doc_number] => 06048514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Amylin activity assays' [patent_app_type] => 1 [patent_app_number] => 8/422747 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 17750 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048514.pdf [firstpage_image] =>[orig_patent_app_number] => 422747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016090 [patent_doc_number] => 05880255 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct of PEG and granulocyte-macrophage colony stimulating factor' [patent_app_type] => 1 [patent_app_number] => 8/422992 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 9401 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880255.pdf [firstpage_image] =>[orig_patent_app_number] => 422992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827694 [patent_doc_number] => 05759996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Peptides useful for altering .alpha..sub.v .beta..sub.3 -mediated binding' [patent_app_type] => 1 [patent_app_number] => 8/421702 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 31907 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759996.pdf [firstpage_image] =>[orig_patent_app_number] => 421702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772546 [patent_doc_number] => 05849865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Peptides for altering bone resorption, angiogenesis and restenosis' [patent_app_type] => 1 [patent_app_number] => 8/421695 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 31991 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849865.pdf [firstpage_image] =>[orig_patent_app_number] => 421695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769274 [patent_doc_number] => 05773412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Use of peptides for altering .alpha..sub.V .beta..sub.3 -mediated binding' [patent_app_type] => 1 [patent_app_number] => 8/421696 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 31304 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 337 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773412.pdf [firstpage_image] =>[orig_patent_app_number] => 421696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772317 [patent_doc_number] => 05807819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Peptides useful for altering bone resorption' [patent_app_type] => 1 [patent_app_number] => 8/421698 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 31296 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 297 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807819.pdf [firstpage_image] =>[orig_patent_app_number] => 421698 [rel_patent_id] =>[rel_patent_doc_number] =>)